Optimal long-term antithrombotic management of atrial fibrillation: life cycle management

Optimal antithrombotic management of atrial fibrillation equals balancing between prevention of arterial thromboembolism, predominantly ischaemic stroke, and haemorrhagic complications. Over time different antithrombotic agents and strategies have been developed. At present, non-vitamin K antagonist...

Descripción completa

Detalles Bibliográficos
Autores principales: Pisters, R., Elvan, A., Crijns, H. J. G. M., Hemels, M. E. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2018
Materias:
Original Article - E‑Learning
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968005/
https://www.ncbi.nlm.nih.gov/pubmed/29722003
http://dx.doi.org/10.1007/s12471-018-1118-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968005/
https://www.ncbi.nlm.nih.gov/pubmed/29722003
http://dx.doi.org/10.1007/s12471-018-1118-0

Ejemplares similares